Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $30,911 - $40,151
1,183 New
1,183 $34,000
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $14,810 - $19,281
-376 Reduced 6.41%
5,492 $224,000
Q4 2022

Feb 15, 2023

BUY
$41.75 - $54.5 $244,989 - $319,806
5,868 New
5,868 $300,000
Q2 2022

Aug 16, 2022

BUY
$46.53 - $55.17 $179,978 - $213,397
3,868 New
3,868 $203,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $176,137 - $218,256
-3,850 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $159,082 - $235,812
3,850 New
3,850 $227,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $5.66 Million - $8.08 Million
-209,340 Closed
0 $0
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $139,021 - $157,771
4,223 Added 2.06%
209,340 $8.2 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $228,664 - $296,510
7,038 Added 3.55%
205,117 $7.37 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $128,320 - $144,074
3,470 Added 1.78%
198,079 $8.58 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $12,000 - $13,184
320 Added 0.16%
194,609 $8.27 Million
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $783,018 - $892,726
-20,354 Reduced 9.48%
194,289 $8.48 Million
Q3 2018

Nov 15, 2018

BUY
$34.47 - $41.81 $93,654 - $113,597
2,717 Added 1.28%
214,643 $9.46 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $166,614 - $177,628
5,052 Added 2.44%
211,926 $7.69 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $453,185 - $525,758
14,202 Added 7.37%
206,874 $7.34 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $706,974 - $750,124
21,256 Added 12.4%
192,672 $6.98 Million
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $5.31 Million - $5.85 Million
171,416
171,416 $6.12 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Greenwood Gearhart Inc Portfolio

Follow Greenwood Gearhart Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Gearhart Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Gearhart Inc with notifications on news.